Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $6.54, $1.61 better than the analyst estimate of $4.93. Revenue for the quarter came in at $10.7 billion versus the consensus estimate of $8.84 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.